Literature DB >> 5932582

Nasal rejection of experimentally inoculated Staphylococcus aureus: evidence for an immune reaction in man.

N J Ehrenkranz.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5932582

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

Review 1.  Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.

Authors:  J Kluytmans; A van Belkum; H Verbrugh
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Acquisition of Staphylococcus aureus by patients undergoing cytotoxic therapy in an ultra-clean isolation unit.

Authors:  H J Andrews; K D Bagshawe
Journal:  J Hyg (Lond)       Date:  1966-12

3.  Prevention of pseudomonas respiratory infection in a surgical intensive care unit.

Authors:  H C Polk; S Borden; J A Aldrete
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

4.  [Physiopathologic aspects of the upper respiratory pathways: nose, sinus and eustachian tube].

Authors:  R Guillerm; R Riu; R Badré; R Le Den; J Hée
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1971

5.  Immunoglobulins in nasal secretions of infants.

Authors:  A B Cohen; S Goldberg; R L London
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

6.  Correlation between nasal microbiome composition and remote purulent skin and soft tissue infections.

Authors:  Ryan C Johnson; Michael W Ellis; Jeffrey B Lanier; Carey D Schlett; Tianyuan Cui; D Scott Merrell
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

7.  Determinants of acquisition and carriage of Staphylococcus aureus in infancy.

Authors:  Sharon J Peacock; Anita Justice; D Griffiths; G D I de Silva; M N Kantzanou; Derrick Crook; Karen Sleeman; Nicholas P J Day
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Secretory antibody responses in axenic mice to perorally administered Staphylococcus aureus.

Authors:  J L Ebersole; J A Molinari
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

9.  Serum Bacteriostasis of Staphylococcus aureus.

Authors:  N J Ehrenkranz; D F Elliott; R Zarco
Journal:  Infect Immun       Date:  1971-05       Impact factor: 3.441

10.  Violagabriellae variant of Staphylococcus epidermidis on normal human skin.

Authors:  R R Marples
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.